<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
<title>JUR - 2020 - Volume 8</title>
<link href="http://ir.lib.ruh.ac.lk/handle/iruor/9091" rel="alternate"/>
<subtitle/>
<id>http://ir.lib.ruh.ac.lk/handle/iruor/9091</id>
<updated>2026-04-28T23:59:02Z</updated>
<dc:date>2026-04-28T23:59:02Z</dc:date>
<entry>
<title>Relapse profile and recurrence free survival of breast cancer patients  – bridging the gap in Sri Lanka</title>
<link href="http://ir.lib.ruh.ac.lk/handle/iruor/9092" rel="alternate"/>
<author>
<name>Peiris, H.</name>
</author>
<author>
<name>Mudduwa, L.</name>
</author>
<author>
<name>Thalagala, N.</name>
</author>
<author>
<name>Jayathilaka, K.</name>
</author>
<id>http://ir.lib.ruh.ac.lk/handle/iruor/9092</id>
<updated>2022-11-02T07:31:14Z</updated>
<published>2020-09-01T00:00:00Z</published>
<summary type="text">Relapse profile and recurrence free survival of breast cancer patients  – bridging the gap in Sri Lanka
Peiris, H.; Mudduwa, L.; Thalagala, N.; Jayathilaka, K.
bstract: Breast cancer (BC) is the commonest cancer among females in Sri Lanka since 2000. This &#13;
study was designed to determine the profile of recurrences, recurrence free survival (RFS) and the &#13;
impact of the clinico-pathological features on the RFS of BC patients in the Southern Sri Lanka. This &#13;
retro-prospective study included BC patients who sought the services from the &#13;
Immunohistochemistry laboratory at the Department of Pathology, Faculty of Medicine, University &#13;
of Ruhuna from May 2006 to December 2012. Tumour grading and scoring for estrogen receptor &#13;
(ER), progesterone receptor (PR) and Her2 were done by principle investigator. The Chi-square test, &#13;
Kaplan-Meier model and the Cox-regression model were used for data analysis using SPSS. A total &#13;
of 923 BC patients were included. Of 923 out of the total, 188 had at least one recurrence (local-34, &#13;
distant-154) during a mean follow up period of 45 months. Five year RFS was 74% (local- 94%, &#13;
distance-78%). The RFS decreased with the increasing tumour size (p=0.002), Nottingham grade &#13;
(p=0.002), lymph-node stage (p&lt;0.001), pathological stage (p&lt;0.001), NPI (p=&lt;0.001) and with the &#13;
presence of lympho-vascular invasion (p=0.011). ER positive (p=0.032), PR positive (p=0.008) and &#13;
Her2 negative (p=0.025) tumours had an increased RFS. In the multivariate analysis, lymph node &#13;
stage1-3 (p&lt;0.001), Nottingham grade 3 (p=0.006) and expression of PR (p=0.024) became &#13;
significant. Lymph node stage, Nottingham Grade and expression of PR have an independent effect &#13;
on the RFS of BC patients in Southern Sri Lanka. Lymph node stage is the best predictor of recurrent &#13;
breast cancer.
</summary>
<dc:date>2020-09-01T00:00:00Z</dc:date>
</entry>
</feed>
